Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1990-03-23
1991-05-21
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514177, 514178, 514179, 514182, 540 23, 540 95, 540100, A61K 3158, A61K 3156, C07J 7100, C07J 1700
Patent
active
050175688
ABSTRACT:
Invented are substituted acrylate analogues of steroidal synthetic compounds, pharmaceutical compositions containing these compounds, and methods of using these compounds to inhibit steroid 5-.alpha.-reductase. Also invented are intermediates used in preparing these compounds.
REFERENCES:
patent: 3129233 (1964-04-01), Deghenghi
patent: 4191759 (1980-03-01), Johnston et al.
patent: 4317817 (1982-03-01), Blohm et al.
patent: 4361578 (1982-11-01), Alig et al.
patent: 4377584 (1983-03-01), Rasmusson et al.
Hsia and Voight, J. Invest. Dermat. 62:224-227 (1973).
Robaire et al., J. Steroid Biochem. 8:307-310 (1977).
Blohm, T. R., et al., Biochem. Biophys. Res. Comm. 95:273-280 (1980).
Liang, T., et al., J. Steroid Biochem. 19, 385-390 (1983).
Petrow, V., et al., Steroids 38:121-140 (1981).
Cacchi et al., Tet. Letters, 26:1109-1112 (1985).
Neeman, J. Chem. Soc. Perkin I 2297 (1972).
Neeman, J. Chem. Soc. Perkin I 2300 (1972).
Hylarides, J. Org. Chem. 49, 2744 (1984).
Brooks et al., Steroids: 47:1-19 (Jan. 1986).
Ross et al., J. Org. Chem. 29: 2784-2785 (1964).
Holt Dennis A.
Kowalski Conrad J.
Levy Mark A.
Metcalf Brian W.
Tickner Ann M.
Criares Theodore J.
Dustman Wayne J.
Friedman Stanley J.
Lentz Edward T.
SmithKline Beecham Corporation
LandOfFree
Steriod 5-alpha-reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Steriod 5-alpha-reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Steriod 5-alpha-reductase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-238578